The Cooper Companies, Inc.
Financials
Valuation Metrics
The Cooper Companies, Inc.'s Market Cap is $14.48B. At end of 2025 it was $16.12B. Ranked #753 of 3,111 in US market (top 24%), #233 of 1,445 on NASDAQ (top 16%), #47 of 206 in Health Care Equipment & Services (top 23%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $14.48B | US#753/3,111 Sec#47/206 |
| Revenue | $4.23B | US#1,005/3,111 Sec#56/206 |
| Net Income | $236M | US#1,196/3,111 Sec#58/206 |
| Total Assets | $12.48B | US#859/3,111 Sec#40/206 |
| Net Assets | $8.24B | US#495/3,111 Sec#26/206 |
| Employees | 15,000 | US#456/3,111 Sec#45/206 |
| Value | ||
| P/E | 61.42x | US#1,935/3,111 Sec#96/206 |
| P/B | 1.76x | US#1,019/3,111 Sec#54/206 |
| P/S | 3.42x | US#1,906/3,111 Sec#131/206 |
| EV/EBITDA | 19.41x | US#1,807/3,111 Sec#79/206 |
| FCF Yield | 3.93% | US#1,519/3,111 Sec#85/206 |
| Profitability | ||
| ROE | 2.86% | US#2,003/3,111 Sec#97/206 |
| ROA | 1.89% | US#1,648/3,111 Sec#96/206 |
| Op. Margin | 11.77% | US#1,486/3,111 Sec#68/206 |
| Revenue Growth | 7.90% | US#1,462/3,111 Sec#103/206 |
| Earnings Growth | -188.83% | US#2,217/3,111 Sec#114/206 |
| Financial Health | ||
| Debt Ratio | 51.50% | US#593/3,111 Sec#69/206 |
| Total Debt | $2.46B | US#1,042/3,111 Sec#49/206 |
| FCF | $570M | US#812/3,111 Sec#49/206 |
| Cash | $139M | US#1,989/3,111 Sec#124/206 |
| Current Ratio | 1.27x | US#1,900/3,111 Sec#171/206 |
| Net Debt/EBITDA | 2.68x | US#1,545/3,111 Sec#93/206 |
| Dividend | ||
| Div. Growth | 0.00% | US—/3,111 Sec—/206 |
| Performance | ||
| 1Y Return | 4.74% | US#1,953/3,111 Sec#132/206 |
| 1M Return | 0.04% | US#1,472/3,111 Sec#110/206 |
| From 52W High | -17.37% | US#1,627/3,111 Sec#112/206 |
| 1Y MDD | -30.05% | US#1,388/3,111 Sec#53/206 |
| Trading | ||
| Volume | 2,098,769 shares | US#813/3,111 Sec#47/206 |
| Trading Value | $156M | US#657/3,111 Sec#50/206 |
| Per Share | ||
| EPS | $2.04 | US#1,255/3,111 Sec#66/206 |
| BPS | $42.52 | US#537/3,111 Sec#38/206 |
Company Info
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.